Budesonide Capsule, Coated Pellets
Product Images NDC 68382-720

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 68382-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 01

Chemical structure diagrams showing the epimer 22R and epimer 22S of budesonide. The image illustrates the molecular configuration differences between the two epimers of budesonide.*

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 02

Label for Budesonide Delayed-Release Capsules, 3 mg strength, oral coated pellets. The label states a package size of 100 capsules. Manufactured by Cadila Healthcare Ltd. in India and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions and mentions the prescription-only status (Rx only). The NDC number 68382-720-01 is present along with a barcode and branding elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.